Chargement en cours...
PARP Inhibitor PJ34 Protects Mitochondria and Induces DNA-Damage Mediated Apoptosis in Combination With Cisplatin or Temozolomide in B16F10 Melanoma Cells
PARP-1 inhibition has recently been employed in both mono- and combination therapies in various malignancies including melanoma with both promising and contradicting results reported. Although deeper understanding of the underlying molecular mechanisms may help improving clinical modalities, the com...
Enregistré dans:
| Publié dans: | Front Physiol |
|---|---|
| Auteurs principaux: | , , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Frontiers Media S.A.
2019
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6514236/ https://ncbi.nlm.nih.gov/pubmed/31133874 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphys.2019.00538 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|